<DOC>
	<DOCNO>NCT02095405</DOCNO>
	<brief_summary>Stimulants drug often associate cardiac effect . Caffeine , therapeutic xanthine , describe sympathomimetic show stimulatory effect heart . Patients symptomatic cardiac arrhythmia generally inform physician stop significantly reduce caffeine intake . However , spite numerous report review cardiac effect caffeine , remain unclear extent stimulant may detrimental , subgroup patient may vulnerable . The investigator propose evaluate effect caffeine patient previously diagnose cardiac arrhythmia . The result report provide important new information physicians patient regard effect caffeine symptomatic cardiac arrhythmia .</brief_summary>
	<brief_title>A Study Caffeine Cardiac Arrhythmias</brief_title>
	<detailed_description>Caffeine one frequently consume pharmacologic active substance world . The potential effect caffeinated beverage chocolate human health remain great interest . The increased prevalence cardiac arrhythmia general population result great concern potential effect caffeine cardiac arrhythmia . Patients diagnose cardiac dysrhythmia generally inform physician restrict even abstain caffeine , despite lack evidence causal relationship . Although numerous report publish effect caffeine human health , report relation caffeinated beverage chocolate different subgroup patient previously diagnose cardiac arrhythmia , include supraventricular tachycardia ( SVT ) , atrial fibrillation ( AF ) , atrial flutter , ventricular arrhythmia . These patient frequently undergo interventional ablation procedure , potential recurrence arrhythmia . A great knowledge effect caffeine different subgroup patient cardiac arrhythmias thus essential properly guide patient physicians treatment . The objective study evaluate effect caffeine noninvasive and/or invasive mean patient document symptomatic cardiac arrhythmia . One group consist 80 patient Supraventricular Tachycardia ( SVT ) : This group undergo Invasive testing , complete electrophysiology laboratory prior ablation procedure evaluate electrophysiologic effect caffeine placebo human heart . This test include measure effective refractory period , inducibility tachyarrhythmias , conduction interval program electrical stimulation . The group consist 80 patient Atrial Fibrillation : This group undergo non-invasive testing , consist two consecutive 48-hr Ambulatory monitor consume caffeinated noncaffeinated product .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Supraventricular</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<criteria>Age 1880 year . Document cardiac arrhythmia , consist either : . Patients SVT : Patients document narrow complex tachycardia twelve lead ECG ambulatory monitoring ii . Patients AF , paroxysmal ( selfterminating AF within 7 day ) , document twelve lead ECG ambulatory monitoring Failure provide inform consent Pregnancy determine preprocedure pregnancy test , woman breastfeed Class III IV congestive heart failure Myocardial infarction within last 6 month Coronary stenting cardiac surgery within last 6 month History unstable angina Uncontrolled hypertension Intolerance caffeinated beverage chocolate Dependency medication may severely react caffeine : substrate Cytochrome P450 1A2 ( CYP1A2 ) ( tizanidine ) , inhibit CYP1A2 ( fluvoxamine , ketoconazole , rofecoxib ) , induce CYP1A2 ( aminoglutethimide , carbamazepine , phenobarbital , rifampin ) Enrolment another study University Ottawa Heart Institute ( UOHI ) , unless approve Human Ethics Review Board ( HREB ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Supraventricular Tachycardia</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Electrophysiology Study</keyword>
	<keyword>Programmed Electrical Stimulation</keyword>
</DOC>